Is Alkermes (ALKS) Offering Value After Recent Share Price Weakness And DCF Upside Signals
- If you are wondering whether Alkermes at around US$27.77 is offering genuine value or just looks cheap on the surface, you are in the right place.
- The share price has seen a 5.2% decline over the last week, a 20.3% decline over the last month and is also down 1.7% year to date and 16.9% over the past year, even though the 3 year and 5 year returns sit at 6.0% and 40.0% respectively.
- These mixed return numbers sit against an ongoing backdrop where investors are reassessing risk and potential across the wider pharmaceuticals and biotech space, and Alkermes is part of that conversation. For a stock that has delivered positive 3 year and 5 year returns but weaker recent performance, many investors are rechecking what they are paying…
Source link
